InsiderBoltOpen live tracker
Home › Stocks › MAZE insider trading

MAZE insider trading — Maze Therapeutics, Inc.

Over the last 90 days, insiders at Maze Therapeutics, Inc. (MAZE) made 0 open-market purchases worth $0 and 8 open-market sales worth $1.14M, making them net sellers by $1.14M. The largest sale was by Coloma Jason V (Chief Executive Officer), who sold 11,227 shares for $297K on Sep 2, 2026.

Updated Oct 16, 2026.

Insider buying · 90d
$0
Insider selling · 90d
$1.14M
Net · 90d
−$1.14M
Last 30 days
0B / 0S

Scan MAZE live in the tracker

Recent MAZE insider transactions

Every Form 4 filed by Maze Therapeutics, Inc. officers, directors and 10% owners in the last 90 days, newest first. P = open-market purchase, S = open-market sale; other codes are awards, option exercises, tax withholding or gifts.

Trade dateInsiderRoleTypeOwnershipSharesPriceValueFiling
Oct 1, 2026Coloma Jason VChief Executive OfficerS · Sale · 10b5-1Indirect34,501$27.02$932KForm 4
Oct 1, 2026Bernstein HaroldPresident, R&D & CMOM · Option exercise · 10b5-1Direct16,141$10.42$168KForm 4
Oct 1, 2026Bernstein HaroldPresident, R&D & CMOS · Sale · 10b5-1Direct16,141$26.93$435KForm 4
Sep 29, 2026Dandekar AtulCSBOM · Option exercise · 10b5-1Direct7,500$10.42$78KForm 4
Sep 29, 2026Dandekar AtulCSBOS · Sale · 10b5-1Direct7,500$27.06$203KForm 4
Sep 4, 2026Bernstein HaroldPresident, R&D & CMOS · Sale · 10b5-1Direct9,705$26.22$255KForm 4
Sep 3, 2026Courtney PhillipsGC and Corp. SecretaryS · SaleDirect2,012$26.01$52KForm 4
Sep 2, 2026Courtney PhillipsGC and Corp. SecretaryS · SaleDirect1,981$26.47$52KForm 4
Sep 3, 2026Dandekar AtulCSBOS · SaleDirect3,243$26.01$84KForm 4
Sep 2, 2026Dandekar AtulCSBOS · SaleDirect3,191$26.47$84KForm 4
Sep 3, 2026Coloma Jason VChief Executive OfficerS · SaleDirect11,411$26.01$297KForm 4
Sep 2, 2026Coloma Jason VChief Executive OfficerS · SaleDirect11,227$26.47$297KForm 4
Sep 3, 2026Bernstein HaroldPresident, R&D & CMOS · SaleDirect5,189$26.01$135KForm 4
Sep 2, 2026Bernstein HaroldPresident, R&D & CMOS · SaleDirect5,106$26.47$135KForm 4
Sep 1, 2026Courtney PhillipsGC and Corp. SecretaryM · Option exerciseDirect11,000——Form 4
Sep 1, 2026Dandekar AtulCSBOM · Option exerciseDirect12,500——Form 4
Sep 1, 2026Coloma Jason VChief Executive OfficerS · Sale · 10b5-1Indirect34,501$26.29$907KForm 4
Sep 1, 2026Coloma Jason VChief Executive OfficerM · Option exercise · 10b5-1Direct50,000——Form 4
Sep 1, 2026Bernstein HaroldPresident, R&D & CMOM · Option exercise · 10b5-1Direct36,141$10.42$168KForm 4
Sep 1, 2026Bernstein HaroldPresident, R&D & CMOS · Sale · 10b5-1Direct16,141$26.36$426KForm 4
Aug 28, 2026Dandekar AtulCSBOM · Option exercise · 10b5-1Direct7,500$10.42$78KForm 4
Aug 28, 2026Dandekar AtulCSBOS · Sale · 10b5-1Direct7,500$27.58$207KForm 4
Aug 13, 2026Bernstein HaroldPresident, R&D & CMOM · Option exercise · 10b5-1Direct16,142$10.42$168KForm 4
Aug 13, 2026Bernstein HaroldPresident, R&D & CMOS · Sale · 10b5-1Direct16,142$27.61$446KForm 4
Aug 3, 2026Coloma Jason VChief Executive OfficerS · Sale · 10b5-1Indirect34,501$26.73$922KForm 4
Jul 29, 2026Dandekar AtulCSBOM · Option exercise · 10b5-1Direct7,500$10.42$78KForm 4
Jul 29, 2026Dandekar AtulCSBOS · Sale · 10b5-1Direct7,500$27.34$205KForm 4

MAZE insider trading FAQ

Are insiders buying MAZE stock?

Not on the open market. In the last 90 days, Maze Therapeutics, Inc. insiders made no open-market purchases, and 8 open-market sales totaling $1.14M. Purchases with the insider's own money are generally seen as a stronger signal than sales, which happen for many reasons (taxes, diversification, planned 10b5-1 sales).

Who are the insiders trading MAZE?

Recent sellers: Bernstein Harold, Coloma Jason V, Courtney Phillips, Dandekar Atul.

Where does MAZE insider trading data come from?

Every transaction comes from SEC Form 4 filings on EDGAR. Company officers, directors and 10% owners must file a Form 4 within two business days of buying or selling. InsiderBolt reads these filings directly from the SEC.

More stocks with insider activity

Insider trading data is for informational purposes only and is not investment advice. Filings can be amended; always confirm details on SEC EDGAR.